SynthesisFrontiers in pharmacology2024

Efficacy and safety of lebrikizumab for the treatment of moderate-to-severe atopic dermatitis: a systematic review and meta-analysis.

Jinger Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.